Skip to content

A Heart of Gold to an Iron Fist: Compassion Fatigue and Resiliency

The term “compassion fatigue” was coined in 1995 to describe the emotional exhaustion resulting from continuous care-giving to those in need. While often used synonymously with “burnout,” the two terms are unique. Given the recent spike in sensitivity to mental health well-being, medical professionals are becoming more mindful of compassion fatigue and its impact on themselves, patient safety, professional satisfaction, and personal dealings. Medical literature recognizes the pervasiveness of compassion fatigue throughout the spectrum of health professions, however, most discussions are focused on disciplines other than pharmacy. In a dichotomous era of increased pharmacist involvement in direct patient care and concerns for unmanageable workloads, long hours, and job dissatisfaction, the call for early recognition of compassion fatigue and provision of well-being resources, has come. During this CE activity, pharmacists will learn how to recognize the symptoms of compassion fatigue in themselves, their colleagues, and their trainees, familiarize themselves with practical well-being plans, and formulate ways to establish supportive resources to prevent and handle compassion fatigue within their respective institutions and departments of pharmacy

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Recognize the signs and symptoms of burnout and compassion fatigue
  • Evaluate the rationale for the importance of compassion fatigue awareness in the pharmacy profession
  • Design a pragmatic self-care/resiliency schedule to proactively handle compassion fatigue
  • Propose implementation strategies for a departmental compassion fatigue prevention and mitigation program

Presenter

Loriel Solodokin, PharmD
Dr. Loriel Solodokin grew up in Brooklyn, NY, and received her Bachelor of Arts in Chemistry and Biology and Associate of Arts in Judaic Studies, from Stern College for Women, Yeshiva University, in 2010. She went on to obtain her Doctor of Pharmacy Degree from the University of Illinois at Chicago College of Pharmacy, in 2014. Being intrigued by clinical pharmacy, Dr. Solodokin pursued her PGY-1 Pharmacy Residency training at New York University Langone Medical Center, in 2015, and ultimately followed her passion for oncology by completing her PGY-2 Oncology Pharmacy Residency at Mount Sinai Hospital in New York, in 2016. Dr. Solodokin currently works as a Clinical Assistant Professor at the Massachusetts College of Pharmacy and Health Sciences University School of Pharmacy and her practice site is at the Dana Farber Cancer Center/Brigham and Women’s Hospital. Her professional interests include hematologic malignancies, stem cell transplantation, infectious diseases, supportive care, and academia.

Registration Fee: This module is provided free of charge to all.

Register


Release Date: June 23, 2020
Expiration Date: June 23, 2023
Contact Hours: 1.5
ACPE UAN: 0026-0000-20-013-H04-P
ACPE Topic Designator: General Pharmacy

Accreditation

ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1.5 contact hours (0.15 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-test, and evaluation. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

It is the policy of MCPHS-CE to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals engaged in the planning of a continuing education activity and who are in a position to control the educational content are required to disclose any financial relationships with ineligible companies occurring within the past 24 months. The intent of this policy is to identify and mitigate any potential conflict of interest that may directly or indirectly affect the activity. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

MCPHS will identify, review and mitigate all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Loriel Solodokin has no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.